06.06.23 -- How To Navigate The Patenting Challenges Of AI-Assisted Drug Discovery

Explore 2023 cybersecurity predictions regarding incidence response, cyberattackers, SMBs, and more. Additionally, discover practical resources that you can review to improve your cyber preparedness.

As protein engineering and manufacturing technologies evolve, there is a need for flexible, customized strategies that balance cost, speed, and risk to accelerate development and approval of biotherapeutics.

A company was seeking a CDMO partner with the expertise and technological capabilities to combine three drug substances into a fixed-dose combination product suitable for adult and pediatric dosing.

Learn how a partner with the right scale-up and commercial production expertise was able to find a cost-effective process to produce API for a new drug.

Experts answer questions from a recent webinar about the challenges when moving a bioconjugate candidate from early development to the clinic, as well as key considerations for de-risking this journey.

As the cost of developing a biologic drug remains high, explore ways to improve your CLD process by eliminating bottlenecks in clone selection, fast-tracking timelines, and reducing costs.